Join to View Full Profile
9555 SW Barnes RdSte 150Portland, OR 97225
Phone+1 503-297-7403
Fax+1 503-384-9908
Dr. Andersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2002- University of Kansas School of MedicineResidency, Internal Medicine, 1996 - 1999
- University of Kansas School of MedicineClass of 1996
Certifications & Licensure
WA State Medical License 2004 - 2026
OR State Medical License 2004 - 2025
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care...Heather L McArthur, Sara M Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah
Therapeutic Advances in Medical Oncology. 2025-01-01 - 6 citationsNeoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen
Breast Cancer. 2024-09-01 - 15 citationsNeoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Joanne L Blum
The Oncologist. 2023-10-03
Press Mentions
Preparing for a Baby After Cancer - US NewsJune 19th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
